Canada’s only integrated cancer research centre, addressing cancer from bench to bedside to boardroom of dedicated research space.
The Queen's Cancer Research Institute (QCRI) was established in 2001. The open concept building was designed to accommodate three major cancer research groups already located at the University, and to provide space for new cancer research initiative. The four-storey Institute is directly connected to previously existing cancer research laboratories in the adjacent Health Sciences building, providi
ng a total of approximately 60,000 sq.ft. Research in the Institute extends from population studies of cancer etiology, through tumor biology and clinical trials, to outcomes and health services research. The Institute is committed to fostering transdisciplinary investigation of areas of cancer control that lie at the interface between fundamental, clinical and population research. The three divisions of the Institute are presently populated by approximately 250 faculty, graduate and post-doctoral trainees and support staff. Opportunities for graduate and post-doctoral training are offered in partnership with several departments at the University, including: Biomedical & Molecular Sciences (including former departments of Anatomy & Cell Biology, Biochemistry, Microbiology & Immunology, and Pharmacology & Toxicology), Community Health & Epidemiology, Mathematics & Statistics, Oncology, Pathology & Molecular Medicine, and the Queen's School of Policy Studies. The Institute also operates a training program in transdisciplinary cancer research, supported by the Terry Fox Foundation in partnership with the Canadian Institutes of Health Research, that is tailored to meet the needs of graduate and post-doctoral trainees from a wide range of disciplines.
Operating as usual
We're excited to share our Spring 2022 Newsletter! To see what's been happening here at QCRI, head on over to our website (link below). If you'd like to be added to our Newsletter email list, please let us know via email: [email protected]
https://us3.campaign-archive.com/?u=9b4f2f3ee9102a9eb94798f29&id=fe5a7632c3
Congratulations to our CCTG division for receiving a 5-year $30M grant renewal from Canadian Cancer Society! https://www.newswire.ca/news-releases/successful-30-million-canadian-cancer-society-grant-renewal-for-the-canadian-cancer-trials-group-896257998.html
/CNW/ - The Canadian Cancer Society (CCS) has renewed its support of the Canadian Cancer Trials Group (CCTG) with a five-year 30-million-dollar commitment to...
Save the date! Next up in our monthly seminar series is Dr. John Stagg on Mon 2 May 2022 at 12pm EST. Hosted by our CBG division's Dr. Madhuri Koti. For Zoom information, please email: [email protected]
QCRI is excited to host a record number of summer studentships via the Craig Jury Memorial Summer Studentship & Weaver fund competitions. Congratulations to all 8 recipients and their supervisors!
If you missed our monthly seminar presented by Dr. Joseph Pater today, it is now available to watch on our wesite! https://qcri.queensu.ca/about-us/seminars-events
Cancer treatment is a waiting game, and it's not just those receiving care who are impatient. A fabulous talk by our CCTG Division's Senior Investigator Dr. Annette Hay You can watch here:
https://www.youtube.com/watch?v=F0cgYxbQywE
Cinq à Sept Research Talks - Queen's Health Scienceshttps://healthsci.queensu.ca/5a7“On Gratitude, Impatience, and Cell Therapy” - Feb 24, 2022*This talk was...
Save the date for our next monthly seminar! We are excited to announce our speaker is Dr. Joseph L. Pater on Mon Apr 4, 2022 at 12pm (EST). For Zoom details, please email [email protected]
Our monthly seminar presented by Dr. Hansen He earlier today is now available for viewing on our website! https://qcri.queensu.ca/about-us/seminars-events
Seminars & Events QCRI Seminar Series - Frontiers in Cancer Research March 7, 2022 | The RNA epigenetics-m6A epitranscriptomic regulation in cancer Feb 7, 2022 | Where are we up to with biomarkers in cancer immunotherapy? Dr. Andrew Miles Jan 10, 2022 | - Personal Reflections on Over 35 Years of Can...
Congratulations to our CBG division's, Dr. Peter Greer, on receiving a 3-year $450K Challenge Grant from Canadian Cancer Society!!!!
Our first Newsletter of 2022 is out! You can check it out, along with our other Newsletters, on our website! https://qcri.queensu.ca/about-us/qcri-newsletters
Some of our amazing scientists on and we're celebrating! Moving cancer research forward everyday of the year.
Next up in our monthly seminar series - Dr. Hansen He! Hosted by
Dr. Gaudreau of our CCTG division. Mon Mar 7, 2022 at 12pm (EST). For Zoom details, please email [email protected]
Our monthly seminar presented by Dr. Andrew Miles is now available for viewing on our website! https://qcri.queensu.ca/about-us/seminars-events
Seminars & Events QCRI Seminar Series - Frontiers in Cancer Research Feb 7, 2022 | Where are we up to with biomarkers in cancer immunotherapy? Dr. Andrew Miles Jan 10, 2022 | - Personal Reflections on Over 35 Years of Cancer Research Elizabeth Eisenhauer, OC MD FRCPC FRSC Nov 1, 2021 | STAT1-induced...
Queen’s Relay for Life 2022 is just over a month away! Don’t miss out on the biggest and best relay Queen’s has ever seen being held on March 13th, 2022! Make history with us at relayforlife.ca/queensu! Relay for Life is a non-competitive relay where teams of students get together and fundraise to support the Canadian Cancer Society. Join us for an amazing event that funds research projects, provides support services for cancer patients and creates awareness campaigns about cancer prevention and general health.
Got questions? Send us a DM or email us at [email protected].
Help us show that no one faces cancer alone. Come to a Relay For Life event near you.
"Cancer touches everybody". From our CCTG division's Director, Dr. Janet Dancey:
https://www.queensu.ca/gazette/stories/trialled-and-true
Clinical trials at Queen’s University help determine life-changing diagnostics, treatments and prevention methods for cancer. In celebration of the 25th anniversary of the Canada Foundation for Innovation (CFI), we are profiling one of our CFI Major Science Initiatives, The Canadian Cancer Trials ...
On this : Dr. Christopher Booth, our CCE division's Director writes about overcoming the barriers to equitable high-quality cancer system.
https://www.thestar.com/opinion/contributors/2022/02/03/world-cancer-day-finding-our-away-again-in-cancer-care.html?rf
One in four Canadians will die of cancer. We need to recalibrate the priorities of our system and take the power back from drug companies.
Today is . Queen's is Highlighting Leaders in Cancer Research on World Cancer Day 2022. Many of our QHS researchers are showcased in this Queen's Gazette feature:
https://www.queensu.ca/gazette/stories/leaders-cancer-research
To recognize World Cancer Day, Queen’s is highlighting current partnerships and research projects to develop novel treatments, support better outcomes, and advance quality of life for people with cancer globally.
Congratulations to our CCTG's division, Dr. Lesley Seymour on her ESMO TAT Honorary Award! More information on ESMO TAT Honorary Awards can be found here: https://www.esmo.org/about-esmo/awards/tat-honorary-award
Congratulations to our CCE Division's Dr. Bishal Gyawali for this fantastic recognition as Outstanding Young Researcher from Asia-Pacific countries!
We are excited to announce our next monthly QCRI seminar speaker! Dr. Miles Andrews on Mon 7 Feb 2022 at 3pm EST. Hosted by Dr. Pierre-Olivier Gaudreau. For Zoom details, please email [email protected]
Dr. Patricia Tonin and her team at the RI-MUHC have discovered a new gene associated to the risk of developing ovarian cancer. Ovarian cancer affects approximately 3000 women per year in Canada. Although most cases are sporadic, there are hereditary forms of ovarian cancer that are largely attributed to mutations in the BRCA1 and BRCA2 genes, which are also involved in breast cancer. Their findings, published in Genome Medicine, show that a mutation in the FANCI gene is more common in ovarian cancer patients with a family history of ovarian cancer than in cancer-free people, suggesting that it may influence the risk of developing that cancer.
https://muhc.ca/news-and-patient-stories/news/fanci-new-gene-origin-some-cases-ovarian-cancer
Congratulations and welcome to our new Director, Dr. Andrew Craig! And a huge thank you to our previous Director, Dr. David Berman and our Interim Director, Dr. Michael Brundage.
We are thrilled to announce our first speaker of 2022 in our monthly seminar series - Dr. Elizabeth Eisenhauer - on Mon Jan 10 at 12:00 pm (EST). Hosted by Dr. Bishal Gyawali
Next up in our monthly seminar series is Dr. Rozanne Arulanandam from Ottawa Hospital Research Institute! Mon 6 Dec at 12:00pm EST. Please email [email protected] for Zoom details.
Pleased to share our November seminar presented by Dr. Josie-Ursini Siegel Just click our seminar link below!
https://qcri.queensu.ca/about-us/seminars-events
Seminars & Events QCRI Seminar Series - Frontiers in Cancer Research Nov 1, 2021 | STAT1-induced inflammation potentiates oxidative stress to increase the therapeutic impact of complex I inhibitors in breast cancer - Josie Ursini-Siegel, PhD Oct 4, 2021 | Women, power, and the cancer divide - Ophira...
Pleased to announce our next monthly seminar speaker! Dr. Josie Ursini-Siegel will present on Monday November 1st 2021 at 12:00 pm EST. Hosted by Dr. Madhuri from our CBG Division. For Zoom information, please email [email protected]
If you missed this month's fabulous seminar by Dr. Ophira Ginsburg, you can watch it on our website!
https://qcri.queensu.ca/about-us/seminars-events
Seminars & Events QCRI Seminar Series - Frontiers in Cancer Research Oct 4, 2021 | Women, power, and the cancer divide - Ophira Ginsburg, MSc, MD Sept 7, 2021 | Development & application of a molecular classification system for urothelial cancer - Gottfrid Sjödahl, PhD July 19, 2021 | Biomarker Dev...
NEW Announcement!
Michael Brundage, MSc, FRCPC, MD (Interim Director, QCRI) has appointed Christopher Booth, MD, FRCPC as Director, CCE Division, QCRI.
Dr. Booth is a Medical Oncologist and Health Services Researcher. He is a Professor of Oncology and Public Health Sciences and holds the Canada Research Chair in Population Cancer Care.
Dr. Booth studied medicine at Queen’s University. He did postgraduate training in Internal Medicine and Medical Oncology at the University of Toronto followed by a research fellowship with the NCIC Clinical Trials Group. In his clinical practice he provides care to patients with gastrointestinal cancers. Dr. Booth’s research program explores access, quality, and value of cancer care in Canada and globally.
In 2016 Dr. Booth spent a sabbatical as a visiting scientist at the Regional Cancer Centre in Trivandrum, India. He is an Advisor (Health Services Research) to the National Cancer Grid of India, an Honorary Consultant at Pallium India, and a member of the WHO Essential Medicine List Cancer Working Group.
Dr. Booth has published over 250 peer-reviewed manuscripts and has served as research supervisor for >25 trainees.
Please join Dr. Brundage in congratulating Dr. Booth on his appointment as Director, CCE Division, Queen’s Cancer Research Institute.
Congratulations Dr. Michael Brundage, our new interim QCRI Director!
Don't miss next month's seminar! Dr. Ophira Ginsburg will be speaking about "Women, power, and the cancer divide" on Mon. Oct. 4th at 12:00 pm EST.
Next up in our monthly seminar series - Dr. Gottfrid Sjödahl !!!!
Excited to share yesterday's monthly seminar hosted by Dr. Harriet Feilotter & presented by Dr. Jonathan Loree (BC Cancer – Vancouver Centre / The University of British Columbia Center). You can watch it here: https://qcri.queensu.ca/about-us/seminars-events
Seminars & Events QCRI Seminar Series - Frontiers in Cancer Research July 19, 2021 | Biomarker Development in Colorectal Cancer – Preparation Today for Future Success - Jonathan Loree, MD, MSc, FRCPC June 7, 2021 | From the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to ...
A reminder of our next monthly seminar by @BCCancer
Check out our latest Newsletter!
https://us3.campaign-archive.com/?u=9b4f2f3ee9102a9eb94798f29&id=8df3a61180
Welcome Paola Dantonio, MSc and Nikita Arora, MD to QCRI’s Executive Management Committee The QCRI’s Executive Management Committee (EMC) is the Institute’s main governing body. It comprises the QCRI Director, the Directors, and one faculty designate from each Division (Cancer Care and Epidemi...
Super news! An innovative blood test for breast cancer by QCRI's Dr. Christopher Mueller, and -- bonus!-- a behind-the-scenes look at how the project evolved. https://go.nature.com/3waauRp
Triple Negative Breast Cancer (TNBC) remains one of the most difficult forms of breast cancer to manage due to its aggressive nature, its more advanced stage at diagnosis and the general lack of targeted therapies.
10 Stuart St Pathology Suite 302c
Kingston, ON
K7L 3N6
The Queen's Cancer Research Institute is located at 10 Stuart Street, between George and Barrie Streets, and is attached to the back of Botterell Hall. The QCRI main entrance is located on the south-east side of Botterell Hall, or you can gain access through the lobby of Botterell Hall. To reach the Director of the Institute, contact Dr. David M. Berman at [email protected] or his assistant, Maureen Hobbs at [email protected] Contact information for faculty or staff of the divisions of the Institute may be found on the Division or faculty pages or by contacting the administrative offices of each of the divisions: Cancer Biology & Genetics Division Suite 302, 10 Stuart Street Kingston, ON K7L 3N6 Canada Phone: (613) 533-2981 Cancer Care & Epidemiology Division Level 2, 10 Stuart Street Kingston, ON K7L 3N6 Canada Phone: (613) 533-6895 Fax: (613) 533-6794 Cancer Clinical Trials Division Level 0, 10 Stuart Street Kingston, ON K7L 3N6 Canada Phone: (613) 533-6430 Fax: (613) 533-2941
Be the first to know and let us send you an email when Queen's Cancer Research Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Queen's Cancer Research Institute:
Queen's University School of Rehabilitation T
Louise D. Acton Building, 31 George St.Kingston Health Sciences Centre
76 Stuart StreetQueen's Healthcare and Business Conference -
Queen's UniversityPregnancy and Beyond with Heather
120 Clarence StCassandra Mol Certified Athletic Therapist
42 Queen StreetCommunity Midwives of Kingston
391 Barrie StTrendsetter, Wigs & Specialty Hair Studio
573 Princess StreetRejuve-Nation Wellness Experts
772 Princess Street
Elements Natural Therapies & Spa
775 Strand Blvd Unit 4
Enchanted Creations - Tea and Gifts
1559 Hwy 15
Kingston Autism and Behavioural Services
3443 Princess Street